| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-71023 | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NB100-64946-0.05mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NB100-64761-100ug | |||
| BSA Free | NB100-64761-0.05mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP2-49891-0.1mg | |||
| BSA Free | NBP2-49891-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP1-76881SS | |||
![Western Blot: SARM1 Antibody (HL1066) [NBP3-13707] - Mouse tissue extract (50 ug) was separated by 7.5% SDS-PAGE, and the membranes were blotted with SARM1 antibody [HL1066] (NBP3-13707) diluted at 1:1000 and competitor's antibody (#Highly cited antibody) diluted at 1:500. The HRP-conjugated anti-FALSE was used to detect the primary antibody.](http://images.novusbio.com/fullsize/SARM1-Antibody-HL1066-Western-Blot-NBP3-13707-img0003.jpg "<b>Independent Antibodies Validation. </b>Western Blot: SARM1 Antibody (HL1066) [NBP3-13707] - Mouse tissue extract (50 ug) was separated by 7.5% SDS-PAGE, and the membranes were blotted with SARM1 antibody [HL1066] (NBP3-13707) diluted at 1:1000 and competitor's antibody (#Highly cited antibody) diluted at 1:500. The HRP-conjugated anti-FALSE was used to detect the primary antibody.")
![<b>Independent Antibodies Validation. </b>Western Blot: SARM1 Antibody (HL1066) [NBP3-13707] - Various tissue extracts (50 ug) were separated by 7.5% SDS-PAGE, and the membrane was blotted with SARM1 antibody [HL1066] (NBP3-13707) diluted at 1:1000. The HRP-conjugated anti-rabbit IgG antibody (NBP2-19301) was used to detect the primary antibody.](http://images.novusbio.com/fullsize/SARM1-Antibody-HL1066-Western-Blot-NBP3-13707-img0002.jpg)
![ICC/IF:SARM1 Antibody (HL1066) [NBP3-13707]-SH-SY-5Y cells were fixed in 4% paraformaldehyde at RT for 15 min.Green: SARM1 stained by SARM1 antibody [HL1066] diluted at 1:500.Red: alpha Tubulin, a cytoskeleton marker, stained by alpha Tubulin antibody [114] diluted at 1:1000.Blue: Fluoroshield with DAPI.](http://images.novusbio.com/fullsize/nbp3-13707_rabbit-sarm1-mab-hl1066-immunocytochemistry-immunofluorescence-27620241299..jpg)
![Immunohistochemistry-Paraffin-SARM1 Antibody (HL1066) [NBP3-13707] - Mouse tissues.SARM1 stained by SARM1 antibody [HL1066] diluted at 1:100.Antigen Retrieval: Citrate buffer, pH 6.0, 15 min.](http://images.novusbio.com/fullsize/nbp3-13707_rabbit-sarm1-mab-hl1066-immunohistochemistry-paraffin-276202412110..jpg)
![<b>Orthogonal Strategies Validation. </b>Western Blot: SARM1 Antibody (HL1066) [NBP3-13707] - Various whole cell extracts (30 ug) were separated by 7.5% SDS-PAGE, and the membrane was blotted with SARM1 antibody [HL1066] diluted at 1:1000. The HRP-conjugated anti-rabbit IgG antibody was used to detect the primary antibody. Corresponding RNA expression data for the same cell lines are based on Human Protein Atlas program.](http://images.novusbio.com/fullsize/nbp3-13707_rabbit-sarm1-mab-hl1066-1610202419414562.jpg)
![SARM1 antibody [HL1066] detects SARM1 protein by immunofluorescent analysis.Sample: SH-SY-5Y cells were fixed in 4% paraformaldehyde at RT for 15 min.Green: SARM1 stained by SARM1 antibody [HL1066] (NBP3-13707) diluted at 1:500.Red: alpha Tubulin, a cytoskeleton marker, stained by alpha Tubulin antibody [GT114] diluted at 1:1000.Blue: Fluoroshield with DAPI .](http://images.novusbio.com/fullsize/nbp3-13707_rabbit-sarm1-mab-hl1066-immunocytochemistry-immunofluorescence-261120251953520.jpg)
![Various whole cell extracts (30 ug) were separated by 7.5% SDS-PAGE, and the membrane was blotted with SARM1 antibody [HL1066] (NBP3-13707) diluted at 1:1000. The HRP-conjugated anti-rabbit IgG antibody was used to detect the primary antibody. Corresponding RNA expression data for the same cell lines are based on Human Protein Atlas program.](http://images.novusbio.com/fullsize/nbp3-13707_rabbit-sarm1-mab-hl1066-western-blot-26112025183410.jpg)
![Immunohistochemistry-Paraffin: TREM2 Antibody (HL1738) - Azide and BSA Free [NBP3-25728] - TREM2 antibody [HL1738] detects TREM2 protein at cell membrane by immunohistochemical analysis. Sample: Paraffin-embedded human lung cancer. TREM2 stained by TREM2 antibody [HL1738] (NBP3-25728) diluted at 1:200. Antigen Retrieval: Citrate buffer, pH 6.0, 15 min](http://images.novusbio.com/fullsize/nbp3-25728_rabbit-trem2-mab-hl1738-azide-and-bsa-free-212024940820.jpg "Immunohistochemistry-Paraffin: TREM2 Antibody (HL1738) - Azide and BSA Free [NBP3-25728] - TREM2 antibody [HL1738] detects TREM2 protein at cell membrane by immunohistochemical analysis. Sample: Paraffin-embedded human lung cancer. TREM2 stained by TREM2 antibody [HL1738] (NBP3-25728) diluted at 1:200. Antigen Retrieval: Citrate buffer, pH 6.0, 15 min")
![Immunocytochemistry/Immunofluorescence: TREM2 Antibody (HL1738) - Azide and BSA Free [NBP3-25728] - TREM2 antibody [HL1738] detects TREM2 protein at cell membrane and cytoplasm by immunofluorescent analysis. Sample: THP-1 cells were fixed in 4% paraformaldehyde at RT for 15 min. Green: TREM2 stained by TREM2 antibody [HL1738] (NBP3-25728) diluted at 1:250. Blue: Fluoroshield with DAPI .](http://images.novusbio.com/fullsize/nbp3-25728_rabbit-trem2-mab-hl1738-azide-and-bsa-free-2120249425467.jpg)
![Western Blot: TREM2 Antibody (HL1738) - Azide and BSA Free [NBP3-25728] - Non-transfected (-) and transfected (+) 293T whole cell extracts (30 ug) were separated by 12% SDS-PAGE, and the membrane was blotted with TREM2 antibody [HL1738] (NBP3-25728) diluted at 1:500. The HRP-conjugated anti-rabbit IgG antibody was used to detect the primary antibody.](http://images.novusbio.com/fullsize/nbp3-25728_rabbit-trem2-mab-hl1738-azide-and-bsa-free-2120249422617.jpg)
![Sandwich ELISA detection of recombinant E.coli expressed, full-length human TREM2 protein using antibodies as below. Capture: TREM2 antibody [HL1739] (1 ug/mL)Please notice that NBP3-25728 needs to be conjugated to HRP to function as the detection antibody when paired with GTX637387. Please contact us for custom HRP-conjugated antibody.](http://images.novusbio.com/fullsize/nbp3-25728_rabbit-trem2-mab-hl1738-azide-and-bsa-free-elisa-1411202518443414.jpg)
![Indirect ELISA analysis was performed by coating the plate with recombinant E.coli expressed, full-length human TREM2 protein (1215.95-19.07 pM). Coated protein was probed with TREM2 antibody [HL1738] (NBP3-25728) (1 ug/mL). Goat anti-rabbit IgG antibody (HRP) was used to detect the bound primary antibody.](http://images.novusbio.com/fullsize/nbp3-25728_rabbit-trem2-mab-hl1738-azide-and-bsa-free-elisa-1411202518414124.jpg)
![<b>Orthogonal Strategies Validation. </b>Various whole cell extracts (30 ug) were separated by 12% SDS-PAGE, and the membrane was blotted with TREM2 antibody [HL1738] (NBP3-25728) diluted at 1:2000. The HRP-conjugated anti-rabbit IgG antibody was used to detect the primary antibody, and the signal was developed with Trident ECL plus-Enhanced. Corresponding RNA expression data for the same cell lines are based on Human Protein Atlas program.](http://images.novusbio.com/fullsize/nbp3-25728_rabbit-trem2-mab-hl1738-azide-and-bsa-free-western-blot-14112025184488.jpg)
![Sandwich ELISA detection of recombinant E.coli expressed, full-length human TREM2 protein using antibodies as below. Capture: TREM2 antibody [HL1738] (NBP3-25728) (5 ug/mL) Detection: HRP-conjugated TREM2 antibody [HL1739] (1 ug/mL)Please notice that GTX637387 needs to be conjugated to HRP to function as the detection antibody when paired with NBP3-25728. Please contact us for custom HRP-conjugated antibody.](http://images.novusbio.com/fullsize/nbp3-25728_rabbit-trem2-mab-hl1738-azide-and-bsa-free-elisa-141120251843335.jpg)
![Immunocytochemistry/Immunofluorescence: Complement Component C1qA Antibody (7H8) [NB200-539] - staining C1q (green) in human SHSY5Y cells by ICC/IF (Immunocytochemistry/immunofluorescence).](http://images.novusbio.com/fullsize/Complement-Component-C1qA-Antibody-7H8-Chromatin-Immunoprecipitation-NB200-539-img0002.jpg "Immunocytochemistry/Immunofluorescence: Complement Component C1qA Antibody (7H8) [NB200-539] - staining C1q (green) in human SHSY5Y cells by ICC/IF (Immunocytochemistry/immunofluorescence).")
![Western Blot: IL-3 Antibody (3B11) [NBP1-47806] - HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY IL3 (Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-IL3.](http://images.novusbio.com/fullsize/IL-3-Antibody-3B11-Western-Blot-NBP1-47806-img0022.jpg "Western Blot: IL-3 Antibody (3B11) [NBP1-47806] - HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY IL3 (Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-IL3.")
![Immunocytochemistry/Immunofluorescence: IL-3 Antibody (3B11) [NBP1-47806] - Staining of A549 cells using anti-IL3 mouse monoclonal antibody.](http://images.novusbio.com/fullsize/IL-3-Antibody-3B11-Immunocytochemistry-Immunofluorescence-NBP1-47806-img0013.jpg)
![Immunohistochemistry-Paraffin: IL-3 Antibody (3B11) [NBP1-47806] - Staining of paraffin-embedded Adenocarcinoma of Human breast tissue.](http://images.novusbio.com/fullsize/IL-3-Antibody-3B11-Immunohistochemistry-Paraffin-NBP1-47806-img0024.jpg)
![Immunohistochemistry-Paraffin: IL-3 Antibody (3B11) [NBP1-47806] - Staining of paraffin-embedded Adenocarcinoma of Human breast tissue using anti-IL3 mouse monoclonal antibody.](http://images.novusbio.com/fullsize/IL-3-Antibody-3B11-Immunohistochemistry-Paraffin-NBP1-47806-img0014.jpg)
![Immunohistochemistry-Paraffin: IL-3 Antibody (3B11) [NBP1-47806] - Staining of paraffin-embedded Carcinoma of Human kidney tissue using anti-IL3 mouse monoclonal antibody.](http://images.novusbio.com/fullsize/IL-3-Antibody-3B11-Immunohistochemistry-Paraffin-NBP1-47806-img0015.jpg)
![Immunohistochemistry-Paraffin: IL-3 Antibody (3B11) [NBP1-47806] - Staining of paraffin-embedded Carcinoma of Human lung tissue using anti-IL3 mouse monoclonal antibody.](http://images.novusbio.com/fullsize/IL-3-Antibody-3B11-Immunohistochemistry-Paraffin-NBP1-47806-img0016.jpg)
![Immunohistochemistry-Paraffin: IL-3 Antibody (3B11) [NBP1-47806] - Staining of paraffin-embedded Carcinoma of Human pancreas tissue using anti-IL3 mouse monoclonal antibody.](http://images.novusbio.com/fullsize/IL-3-Antibody-3B11-Immunohistochemistry-Paraffin-NBP1-47806-img0017.jpg)
![Immunohistochemistry-Paraffin: IL-3 Antibody (3B11) [NBP1-47806] - Staining of paraffin-embedded Carcinoma of Human thyroid tissue using anti-IL3 mouse monoclonal antibody.](http://images.novusbio.com/fullsize/IL-3-Antibody-3B11-Immunohistochemistry-Paraffin-NBP1-47806-img0018.jpg)
![Immunohistochemistry-Paraffin: IL-3 Antibody (3B11) [NBP1-47806] - Staining of paraffin-embedded Human breast tissue using anti-IL3 mouse monoclonal antibody.](http://images.novusbio.com/fullsize/IL-3-Antibody-3B11-Immunohistochemistry-Paraffin-NBP1-47806-img0019.jpg)
![Immunohistochemistry-Paraffin: IL-3 Antibody (3B11) [NBP1-47806] - Staining of paraffin-embedded Human colon tissue using anti-IL3 mouse monoclonal antibody.](http://images.novusbio.com/fullsize/IL-3-Antibody-3B11-Immunohistochemistry-Paraffin-NBP1-47806-img0020.jpg)
![Immunohistochemistry-Paraffin: IL-3 Antibody (3B11) [NBP1-47806] - Staining of paraffin-embedded Human Kidney tissue using anti-IL3 mouse monoclonal antibody.](http://images.novusbio.com/fullsize/IL-3-Antibody-3B11-Immunohistochemistry-Paraffin-NBP1-47806-img0021.jpg)
![Immunohistochemistry-Paraffin: IL-3 Antibody (3B11) [NBP1-47806] - Staining of paraffin-embedded Human breast tissue.](http://images.novusbio.com/fullsize/IL-3-Antibody-3B11-Immunohistochemistry-Paraffin-NBP1-47806-img0023.jpg)
![Immunohistochemistry-Paraffin: IL-17/IL-17A Antibody (TC11-18H10) - Azide and BSA Free [NBP1-72027] - IL-17/IL-17A Antibody (TC11-18H10) [NBP1-72027] - Treatment with HBOT or PFD decreased IL-17A expression in the AD lesions. IHC for IL-17A on mouse skin. Scale bar is 100 um. The number of IL-17A-expressing cells was counted in five high-power fields (HPF) chosen at random in each slide by three different pathologists. Image collected and cropped by CiteAb from the following publication (//dx.plos.org/10.1371/journal.pone.0109297) licensed under a CC-BY license.](http://images.novusbio.com/fullsize/IL-17-IL-17A-Antibody-TC11-18H10-Immunohistochemistry-Paraffin-NBP1-72027-img0003.jpg "Immunohistochemistry-Paraffin: IL-17/IL-17A Antibody (TC11-18H10) - Azide and BSA Free [NBP1-72027] - IL-17/IL-17A Antibody (TC11-18H10) [NBP1-72027] - Treatment with HBOT or PFD decreased IL-17A expression in the AD lesions. IHC for IL-17A on mouse skin. Scale bar is 100 um. The number of IL-17A-expressing cells was counted in five high-power fields (HPF) chosen at random in each slide by three different pathologists. Image collected and cropped by CiteAb from the following publication (//dx.plos.org/10.1371/journal.pone.0109297) licensed under a CC-BY license.")
![Immunohistochemistry-Paraffin: IL-17/IL-17A Antibody (TC11-18H10) [NBP1-72027] - Analysis of anti-IL-17 antibody of mouse spleen at concentration 10 ug/ml.](http://images.novusbio.com/fullsize/IL-17-IL-17A-Antibody-TC11-18H10-Immunohistochemistry-Paraffin-NBP1-72027-img0002.jpg)
![Immunocytochemistry/ Immunofluorescence: IL-17/IL-17A Antibody (TC11-18H10) - Azide and BSA Free [NBP1-72027] - TG2-dependent chemokine production in keratinocytes is critical for IL-17-producing CCR6+ gamma δT-cell & neutrophil dermal infiltration.a, b Effect of DMSO- or IMQ-treated WT- or TG2−/−-CM on CCR6+ gamma δT-cell (a) & CD11b+ Ly-6G+ cell (b) migration according to Transwell migration assays. Flow cytometric analysis of the percentage of cells migrating toward the CM in the presence or absence of anti-CXCL1 (a) & anti-CCL20 (b) antibodies (n = 3/group). c, d WT & TG2−/− mouse-derived CCR6+ gamma δT-cell (c) & CD11b+ Ly-6G+ cell (d) migration in response to recombinant mouse CCL20 & CXCL1, respectively. Data represent the mean ± SEM (n = 3/group). *p < 0.05; **p < 0.01. e, f Cells were isolated from the back skin of WT & TG2−/− mice treated with IMQ for four consecutive days & analyzed by flow cytometry. Representative flow cytometric profiles of CCR6+  gamma δTCRlow cells (e) & CD11bhigh Ly-6G+ cells (f). The percentage of cells is shown. Data represent the mean ± SEM (n = 9/group). g Skin sections were immunostained with CCR6 (green)- & IL-17 (red)-specific antibodies. Nuclei were stained with DAPI (blue). Scale bar, 100 μm. h–j Back skin was separated into epidermis & dermis & analyzed by RT-PCR for IL-17-producing gamma δT-cell markers (h) (Ccr6 & Il23r), IL17 & related cytokines (i) (Il17a, Il17f, & Il22), & myeloid cell-derived cytokines (j) (Il12a & Il23a). Data represent the mean ± SEM (n = 11/group). *p < 0.05; **p < 0.01 vs. WT mice. Image collected & cropped by CiteAb from the following publication (//pubmed.ncbi.nlm.nih.gov/32355189), licensed under a CC-BY license. Not internally tested by Novus Biologicals.](http://images.novusbio.com/fullsize/nbp1-72027_rat-il-17-il-17a-mab-tc11-18h10-azide-and-bsa-free-310202416171471.jpg)
![Immunocytochemistry/Immunofluorescence: Macrophage Antibody (MOMA-2) [NB100-64946] - Cabanel M, Brand C, Oliveira-Nunes MC, Cabral-Piccin MP, Lopes MF, Brito JM, et al. (2015) Epigenetic Control of Macrophage Shape Transition towards an Atypical Elongated Phenotype by Histone Deacetylase Activity. PLoS ONE 10(7): e0132984.](http://images.novusbio.com/fullsize/Macrophage-Antibody-MOMA-2-Immunocytochemistry-Immunofluorescence-NB100-64946-img0022.jpg "Immunocytochemistry/Immunofluorescence: Macrophage Antibody (MOMA-2) [NB100-64946] - Cabanel M, Brand C, Oliveira-Nunes MC, Cabral-Piccin MP, Lopes MF, Brito JM, et al. (2015) Epigenetic Control of Macrophage Shape Transition towards an Atypical Elongated Phenotype by Histone Deacetylase Activity. PLoS ONE 10(7): e0132984.")
![Immunohistochemistry: Macrophage Antibody (MOMA-2) [NB100-64946] - Benard A, Sala C, Pluschke G (2016)Mycobacterium ulcerans Mouse Model Refinement for Pre-Clinical Profiling of Vaccine Candidates.PLoS ONE 11(11): e0167059](http://images.novusbio.com/fullsize/Macrophage-Antibody-MOMA-2-Immunohistochemistry-NB100-64946-img0026.jpg)
![Flow Cytometry: Macrophage Antibody (MOMA-2) [NB100-64946] - Staining of mouse peritoneal macrophages with RPE conjugated Rat anti Mouse Macrophages/Monocytes following permeabilisation with Leucoperm](http://images.novusbio.com/fullsize/Macrophage-Antibody-MOMA-2-Flow-Cytometry-NB100-64946-img0007.jpg)
![Immunocytochemistry/Immunofluorescence: Macrophage Antibody (MOMA-2) [NB100-64946] - Nix RN, Altschuler SE, Henson PM, Detweiler CS (2007) Hemophagocytic Macrophages Harbor Salmonella enterica during Persistent Infection.PLoS Pathog 3(12): e193.](http://images.novusbio.com/fullsize/Macrophage-Antibody-MOMA-2-Immunocytochemistry-Immunofluorescence-NB100-64946-img0010.jpg)
![Immunocytochemistry/Immunofluorescence: Macrophage Antibody (MOMA-2) [NB100-64946] - Nix RN, Altschuler SE, Henson PM, Detweiler CS (2007) Hemophagocytic Macrophages Harbor Salmonella enterica during Persistent Infection.](http://images.novusbio.com/fullsize/Macrophage-Antibody-MOMA-2-Immunocytochemistry-Immunofluorescence-NB100-64946-img0011.jpg)
![Immunocytochemistry/Immunofluorescence: Macrophage Antibody (MOMA-2) [NB100-64946] - Nix RN, Altschuler SE, Henson PM, Detweiler CS (2007) Hemophagocytic Macrophages Harbor Salmonella enterica during Persistent Infection.PLoS Pathog 3(12): e193.](http://images.novusbio.com/fullsize/Macrophage-Antibody-MOMA-2-Immunocytochemistry-Immunofluorescence-NB100-64946-img0012.jpg)
![Immunocytochemistry/Immunofluorescence: Macrophage Antibody (MOMA-2) [NB100-64946] - Dong M, Zhong L, Chen WQ, Ji XP, Zhang M, Zhao YX, et al. (2012) Doxycycline Stabilizes Vulnerable Plaque via Inhibiting Matrix Metalloproteinases and Attenuating Inflammation in Rabbits.PLoS ONE 7(6): e39695.](http://images.novusbio.com/fullsize/Macrophage-Antibody-MOMA-2-Immunocytochemistry-Immunofluorescence-NB100-64946-img0014.jpg)
![<b>Genetic Strategies Validation. </b>Immunohistochemistry: Macrophage Antibody (MOMA-2) [NB100-64946] - Marie-Claude Bourdillon, Jacques Randon, Lydie Barek, et al.,](http://images.novusbio.com/fullsize/Macrophage-Antibody-MOMA-2-Immunohistochemistry-NB100-64946-img0006.jpg)
![Immunohistochemistry: Macrophage Antibody (MOMA-2) [NB100-64946] - Ruschke K, Ebelt H, Kloting N, Boettger T, Raum K, Bluher M, et al. (2009) Defective Peripheral Nerve Development Is Linked to Abnormal Architecture and Metabolic Activity of Adipose Tissue in Nscl-2 Mutant Mice.PLoS ONE 4(5): e5516.](http://images.novusbio.com/fullsize/Macrophage-Antibody-MOMA-2-Immunohistochemistry-NB100-64946-img0009.jpg)
![<b>Genetic Strategies Validation. </b>Immunohistochemistry: Macrophage Antibody (MOMA-2) [NB100-64946] - Seno T, Hamaguchi M, Ashihara E, Kohno M, Ishino H, Yamamoto A, et al. (2011) 15-Deoxy-delta 12,14 Prostaglandin J2 Reduces the Formation of Atherosclerotic Lesions in Apolipoprotein E Knockout Mice. PLoS ONE 6(10): e25541.](http://images.novusbio.com/fullsize/Macrophage-Antibody-MOMA-2-Immunohistochemistry-NB100-64946-img0013.jpg)
![Immunohistochemistry: Macrophage Antibody (MOMA-2) [NB100-64946] - Chyu K-Y, Zhao X, Dimayuga PC, Zhou J, Li X, Yano J, et al. (2012) CD8+ T Cells Mediate the Athero-Protective Effect of Immunization with an ApoB-100 Peptide.PLoS ONE 7(2): e30780.](http://images.novusbio.com/fullsize/Macrophage-Antibody-MOMA-2-Immunohistochemistry-NB100-64946-img0015.jpg)
![Immunohistochemistry: Macrophage Antibody (MOMA-2) [NB100-64946] - Wang B, Dai S, Dong Z, Sun Y, Song X, Guo C, et al. (2014) The Modulation of Endoplasmic Reticulum Stress by Chemical Chaperone Upregulates Immune Negative Cytokine IL-35 in Apolipoprotein E-Deficient Mice.PLoS ONE 9(1): e87787.](http://images.novusbio.com/fullsize/Macrophage-Antibody-MOMA-2-Immunohistochemistry-NB100-64946-img0016.jpg)
![<b>Genetic Strategies Validation. </b>Immunohistochemistry: Macrophage Antibody (MOMA-2) [NB100-64946] - Liu XL, Zhang PF, Ding SF, Wang Y, Zhang M, Zhao YX, et al. (2012) Local Gene Silencing of Monocyte Chemoattractant Protein-1 Prevents Vulnerable Plaque Disruption in Apolipoprotein E-Knockout Mice.PLoS ONE 7(3): e33497.](http://images.novusbio.com/fullsize/Macrophage-Antibody-MOMA-2-Immunohistochemistry-NB100-64946-img0017.jpg)
![Immunohistochemistry: Macrophage Antibody (MOMA-2) [NB100-64946] - Chyu K-Y, Lio WM, Dimayuga PC, Zhou J, Zhao X, Yano J, et al. (2014) Cholesterol Lowering Modulates T Cell Function In Vivo and In Vitro. PLoS ONE 9(3): e92095.](http://images.novusbio.com/fullsize/Macrophage-Antibody-MOMA-2-Immunohistochemistry-NB100-64946-img0018.jpg)
![Immunohistochemistry: Macrophage Antibody (MOMA-2) [NB100-64946] - Kennedy A, Gruen ML, Gutierrez DA, Surmi BK, Orr JS, Webb CD, et al. (2012) Impact of Macrophage Inflammatory Protein-1a Deficiency on Atherosclerotic Lesion Formation, Hepatic Steatosis, and Adipose Tissue Expansion.PLoS ONE 7(2): e31508.](http://images.novusbio.com/fullsize/Macrophage-Antibody-MOMA-2-Immunohistochemistry-NB100-64946-img0020.jpg)
![Immunohistochemistry: Macrophage Antibody (MOMA-2) [NB100-64946] - Wang L, Yang M, Arias A, Song L, Li F, Tian F, et al. (2015) Splenocytes Seed Bone Marrow of Myeloablated Mice: Implication for Atherosclerosis. PLoS ONE 10(6): e0125961.](http://images.novusbio.com/fullsize/Macrophage-Antibody-MOMA-2-Immunohistochemistry-NB100-64946-img0021.jpg)
![Immunohistochemistry: Macrophage Antibody (MOMA-2) [NB100-64946] - Niven J, Hoare J, McGowan D, Devarajan G, Itohara S, Gannage M, et al. (2015) S100B Up-Regulates Macrophage Production of IL1b and CCL22 and Influences Severity of Retinal Inflammation.PLoS ONE 10(7): e0132688.](http://images.novusbio.com/fullsize/Macrophage-Antibody-MOMA-2-Immunohistochemistry-NB100-64946-img0024.jpg)
![Immunohistochemistry: Macrophage Antibody (MOMA-2) [NB100-64946] - Shuto Y, Asai A, Nagao M, Sugihara H, Oikawa S (2015) Repetitive Glucose Spikes Accelerate Atherosclerotic Lesion Formation in C57BL/6 Mice.PLoS ONE 10(8): e0136840.](http://images.novusbio.com/fullsize/Macrophage-Antibody-MOMA-2-Immunohistochemistry-NB100-64946-img0025.jpg)
![Flow Cytometry: Macrophage Antibody (MOMA-2) [NB100-64946] - Staining of mouse peritoneal macrophages with FITC conjugated Rat anti Mouse Macrophages/Monocytes following permeabilisation with Leucoperm](http://images.novusbio.com/fullsize/Macrophage-Antibody-MOMA-2-Flow-Cytometry-NB100-64946-img0001.jpg)
![Immunocytochemistry/Immunofluorescence: CD25/IL-2 R alpha Antibody (OX-39) [NB100-64761] - Rat lymph node cryosection with Mouse anti Rat CD25 antibody , red in A and Mouse anti Rat CD8, green in B. C is the merged image with nuclei counterstained blue using DAPI. Low power](http://images.novusbio.com/fullsize/CD25-IL-2-R-alpha-Antibody-OX-39-Immunocytochemistry-Immunofluorescence-NB100-64761-img0004.jpg "Immunocytochemistry/Immunofluorescence: CD25/IL-2 R alpha Antibody (OX-39) [NB100-64761] - Rat lymph node cryosection with Mouse anti Rat CD25 antibody , red in A and Mouse anti Rat CD8, green in B. C is the merged image with nuclei counterstained blue using DAPI. Low power")
![Immunohistochemistry-Paraffin: CD25/IL-2 R alpha Antibody (OX-39) [NB100-64761] - Rat lymph node cryosection with Mouse anti Rat CD25 followed by horseradish peroxidase conjugated Goat anti Mouse IgG1 as a detection reagent. Medium power](http://images.novusbio.com/fullsize/CD25-IL-2-R-alpha-Antibody-OX-39-Immunohistochemistry-Paraffin-NB100-64761-img0002.jpg)
![Flow Cytometry: CD25/IL-2 R alpha Antibody (OX-39) [NB100-64761] - Staining of Con A activated rat spleen cells with Mouse anti Rat CD25: Biotin](http://images.novusbio.com/fullsize/CD25-IL-2-R-alpha-Antibody-OX-39-Flow-Cytometry-NB100-64761-img0003.jpg)
![Immunocytochemistry/Immunofluorescence: CD25/IL-2 R alpha Antibody (OX-39) [NB100-64761] - Rat lymph node cryosection with Mouse anti Rat CD25 antibody, red in A and Mouse anti Rat CD8, green in B. C is the merged image with nuclei counterstained blue using DAPI. High power](http://images.novusbio.com/fullsize/CD25-IL-2-R-alpha-Antibody-OX-39-Immunocytochemistry-Immunofluorescence-NB100-64761-img0001.jpg)
![Immunocytochemistry/Immunofluorescence: Complement Component C1qA Antibody (3R9/2) [NB100-64729] - C4d deposition in graft biopsies of patients with DGF. C4d (green, E) co-localized with C1QA (red, G) at peri-tubular capillary sites (merge, I). TO-PRO-3 (blue) was used to stain nuclei. Original magnifications were (E-J) x630.](http://images.novusbio.com/fullsize/Complement-Component-C1qA-Antibody-3R9-2-Immunocytochemistry-Immunofluorescence-NB100-64729-img0006.jpg "Immunocytochemistry/Immunofluorescence: Complement Component C1qA Antibody (3R9/2) [NB100-64729] - C4d deposition in graft biopsies of patients with DGF. C4d (green, E) co-localized with C1QA (red, G) at peri-tubular capillary sites (merge, I). TO-PRO-3 (blue) was used to stain nuclei. Original magnifications were (E-J) x630.")
![Flow Cytometry: Complement Component C1qA Antibody (3R9/2) [NB100-64729]](http://images.novusbio.com/fullsize/Complement-Component-C1qA-Antibody-3R9-2-Flow-Cytometry-NB100-64729-img0007.jpg)
![Flow Cytometry: CD3 Antibody (CA17.2A12) [NBP2-49891] - Figure A. Purified Rat anti Canine CD90 detected with Goat anti Rat IgG2a DyLight 649 and Mouse IgG1 FITC isotype control. Figure B. Purified Rat anti Canine CD90 detected with Goat anti Rat IgG2a PE and Mouse anti Canine CD3 FITC.](http://images.novusbio.com/fullsize/CD3-Antibody-CA17-2A12-Flow-Cytometry-NBP2-49891-img0009.jpg "Flow Cytometry: CD3 Antibody (CA17.2A12) [NBP2-49891] - Figure A. Purified Rat anti Canine CD90 detected with Goat anti Rat IgG2a DyLight 649 and Mouse IgG1 FITC isotype control. Figure B. Purified Rat anti Canine CD90 detected with Goat anti Rat IgG2a PE and Mouse anti Canine CD3 FITC.")
![Flow Cytometry: CD3 Antibody (CA17.2A12) [NBP2-49891] - Figure A: APC conjugated rat anti-Canine CD4 and FITC conjugated mouse IgG1 isotype control. Figure B: APC conjugated rat anti-Canine CD4 and FITC conjugated mouse anti-Canine CD3.](http://images.novusbio.com/fullsize/CD3-Antibody-CA17-2A12-Flow-Cytometry-NBP2-49891-img0001.jpg)
![Flow Cytometry: CD3 Antibody (CA17.2A12) [NBP2-49891] - Figure A: RPE conjugated Rat anti-Dog CD4 and Mouse IgG1 isotype control labeled with Goat anti-Mouse FITC. Figure B: RPE conjugated Rat anti-Dog CD4 and Mouse anti-Dog CD3 labeled with Goat anti Mouse DyLight FITC.](http://images.novusbio.com/fullsize/CD3-Antibody-CA17-2A12-Flow-Cytometry-NBP2-49891-img0002.jpg)
![Flow Cytometry: CD3 Antibody (CA17.2A12) [NBP2-49891] - Figure A. Alexa Fluor 700 conjugated Rat anti Canine CD8 and FITC conjugated Mouse IgG1 isotype control. Figure B. Alexa Fluor 700 conjugated Rat anti Canine CD8 and FITC conjugated Mouse anti Canine CD3.](http://images.novusbio.com/fullsize/CD3-Antibody-CA17-2A12-Flow-Cytometry-NBP2-49891-img0003.jpg)
![Flow Cytometry: CD3 Antibody (CA17.2A12) [NBP2-49891] - Figure A. FITC conjugated Mouse anti Canine CD3 and RPE conjugated Rat IgG2a isotype control. Figure B. FITC conjugated Mouse anti Canine CD3 and RPE conjugated Rat anti Canine CD4.](http://images.novusbio.com/fullsize/CD3-Antibody-CA17-2A12-Flow-Cytometry-NBP2-49891-img0004.jpg)
![Flow Cytometry: CD3 Antibody (CA17.2A12) [NBP2-49891] - Figure A. RPE conjugated Rat anti Canine CD4 and FITC conjugated Mouse IgG1 isotype control. Figure B. RPE conjugated Rat anti Canine CD4 and FITC conjugated Mouse anti Canine CD3.](http://images.novusbio.com/fullsize/CD3-Antibody-CA17-2A12-Flow-Cytometry-NBP2-49891-img0005.jpg)
![Flow Cytometry: CD3 Antibody (CA17.2A12) [NBP2-49891] - Figure A. RPE conjugated Rat anti Canine CD8 and FITC conjugated Mouse IgG1 isotype control. Figure B. RPE conjugated Rat anti Canine CD8 and FITC conjugated Mouse anti Canine CD3.](http://images.novusbio.com/fullsize/CD3-Antibody-CA17-2A12-Flow-Cytometry-NBP2-49891-img0006.jpg)
![Flow Cytometry: CD3 Antibody (CA17.2A12) [NBP2-49891] - Figure A. FITC conjugated Mouse anti Canine CD3 and RPE conjugated Rat IgG1 isotype control. Figure B. FITC conjugated Mouse anti Canine CD3 and RPE conjugated Rat anti Canine CD8.](http://images.novusbio.com/fullsize/CD3-Antibody-CA17-2A12-Flow-Cytometry-NBP2-49891-img0007.jpg)
![Flow Cytometry: CD3 Antibody (CA17.2A12) [NBP2-49891] - Figure A. FITC conjugated Mouse anti Canine CD3 and purified Rat IgG2a isotype control detected with Goat anti Rat IgG2a DyLight 649. Figure B. FITC conjugated Mouse anti Canine CD3 and purified Mouse anti Canine CD90 detected with Goat anti Rat IgG2a DyLight 649.](http://images.novusbio.com/fullsize/CD3-Antibody-CA17-2A12-Flow-Cytometry-NBP2-49891-img0008.jpg)
![Western Blot: TRAILR3/TNFRSF10C Antibody [NBP1-76881] - Analysis of 20 ug of whole cell lysate from HeLa (Lane 1) and 293 (Lane 2) cells with anti-TRAIL-R3 at 1 ug/ml dilution. Image submitted by a verified customer review.](http://images.novusbio.com/fullsize/TRAILR3-TNFRSF10C-Antibody-Western-Blot-NBP1-76881-img0002.jpg "Western Blot: TRAILR3/TNFRSF10C Antibody [NBP1-76881] - Analysis of 20 ug of whole cell lysate from HeLa (Lane 1) and 293 (Lane 2) cells with anti-TRAIL-R3 at 1 ug/ml dilution. Image submitted by a verified customer review.")
![Western Blot: TRAILR3/TNFRSF10C Antibody [NBP1-76881] - HeLa whole cell lysate with TRAIL-R3 antibody (ED) at 1:500 dilution.](http://images.novusbio.com/fullsize/TRAILR3-TNFRSF10C-Antibody-Western-Blot-NBP1-76881-img0001.jpg)
![Immunocytochemistry/ Immunofluorescence: TRAILR3/TNFRSF10C Antibody - BSA Free [NBP1-76881] - Immunofluorescence of TRAILR3/TNFRSF10C in Hela cells with TRAILR3/TNFRSF10C antibody at 20 ug/mL.](http://images.novusbio.com/fullsize/nbp1-76881_rabbit-polyclonal-trailr3-tnfrsf10c-antibody-2711202420324822.jpg)
![Immunocytochemistry/ Immunofluorescence: TRAILR3/TNFRSF10C Antibody - BSA Free [NBP1-76881] - Immunocytochemistry of TRAILR3/TNFRSF10C in HeLa cells with TRAILR3/TNFRSF10C antibody at 10 ug/mL.](http://images.novusbio.com/fullsize/nbp1-76881_rabbit-polyclonal-trailr3-tnfrsf10c-antibody-271120242074690.jpg)
![Western Blot: PBEF/Visfatin/NAMPT Antibody (BLR058F) [NBP2-76368] - Detection of human and mouse NAMPT/PBEF/Visfatin by WB of RKO, MCF-7, K-562, GaMG, HEK293T, HeLa, U2OS, LNCaP, Hep-G2, Jurkat, and NIH 3T3 lysate. Antibody: Rabbit anti-NAMPT/PBEF/Visfatin recombinant monoclonal [BLR058F] (NBP2-76368). Secondary: HRP-conjugated goat anti-rabbit IgG (A120-101P). Lower Panel: Rabbit anti-GAPDH.](http://images.novusbio.com/fullsize/PBEF-Visfatin-NAMPT-Antibody-BLR058F-Western-Blot-NBP2-76368-img0004.jpg "Western Blot: PBEF/Visfatin/NAMPT Antibody (BLR058F) [NBP2-76368] - Detection of human and mouse NAMPT/PBEF/Visfatin by WB of RKO, MCF-7, K-562, GaMG, HEK293T, HeLa, U2OS, LNCaP, Hep-G2, Jurkat, and NIH 3T3 lysate. Antibody: Rabbit anti-NAMPT/PBEF/Visfatin recombinant monoclonal [BLR058F] (NBP2-76368). Secondary: HRP-conjugated goat anti-rabbit IgG (A120-101P). Lower Panel: Rabbit anti-GAPDH.")
![Immunocytochemistry: PBEF/Visfatin/NAMPT Antibody (BLR058F) [NBP2-76368] - Detection of human NAMPT/PBEF/Visfatin in FFPE NCI-H460 by ICC. Antibody: Rabbit anti-NAMPT/PBEF/Visfatin recombinant monoclonal [BLR058F] (NBP2-76368). Secondary: HRP-conjugated goat anti-rabbit IgG. Substrate: DAB.](http://images.novusbio.com/fullsize/PBEF-Visfatin-NAMPT-Antibody-BLR058F-Immunocytochemistry-NBP2-76368-img0003.jpg)
![Immunohistochemistry: PBEF/Visfatin/NAMPT Antibody (BLR058F) [NBP2-76368] - Detection of human NAMPT/PBEF/Visfatin in FFPE ovarian carcinoma by IHC. Antibody: Rabbit anti-NAMPT/PBEF/Visfatin recombinant monoclonal [BLR058F] (NBP2-76368). Secondary: HRP-conjugated goat anti-rabbit IgG. Substrate: DAB.](http://images.novusbio.com/fullsize/PBEF-Visfatin-NAMPT-Antibody-BLR058F-Immunohistochemistry-NBP2-76368-img0002.jpg)
![Flow Cytometry: PBEF/Visfatin/NAMPT Antibody (BLR058F) [NBP2-76368] - Rabbit antiNAMPT/PBEF/Visfatin recombinant monoclonal [BLR058F] or isotype control (unshaded). Secondary: DyLight® 650-conjugated goat anti-rabbit IgG.](http://images.novusbio.com/fullsize/PBEF-Visfatin-NAMPT-Antibody-BLR058F-Flow-Cytometry-NBP2-76368-img0006.jpg)
![Immunohistochemistry: PBEF/Visfatin/NAMPT Antibody (BLR058F) [NBP2-76368] - Detection of human NAMPT/PBEF/Visfatin in FFPE breast carcinoma by IHC. Antibody: Rabbit anti-NAMPT/PBEF/Visfatin recombinant monoclonal [BLR058F] (NBP2-76368). Secondary: HRP-conjugated goat anti-rabbit IgG. Substrate: DAB.](http://images.novusbio.com/fullsize/PBEF-Visfatin-NAMPT-Antibody-BLR058F-Immunohistochemistry-NBP2-76368-img0001.jpg)
![<b>Independent Antibodies Validation. </b>Immunoprecipitation: PBEF/Visfatin/NAMPT Antibody (BLR058F) [NBP2-76368] - Detection of human NAMPT/PBEF/Visfatin by WB of immunoprecipitates from HEK293T lysate. Antibodies: Rabbit anti-NAMPT/PBEF/Visfatin recombinant monoclonal [BLR058F] (NBP2-76368), rabbit anti-NAMPT/PBEF/Visfatin antibodies NB100-594, and one other rabbit anti-NAMPT/PBEF/Visfatin antibody.](http://images.novusbio.com/fullsize/PBEF-Visfatin-NAMPT-Antibody-BLR058F-Immunoprecipitation-NBP2-76368-img0005.jpg)
![Western Blot: Survivin Antibody (1H5) [NBP2-22188] - Western blot analysis using Survivin Antibody (1H5) [NBP2-22188] against human BIRC5 (AA: 1-142) recombinant protein. (Expected MW is 16 kDa)](http://images.novusbio.com/fullsize/Survivin-Antibody-1H5-Western-Blot-NBP2-22188-img0007.jpg "Western Blot: Survivin Antibody (1H5) [NBP2-22188] - Western blot analysis using Survivin Antibody (1H5) [NBP2-22188] against human BIRC5 (AA: 1-142) recombinant protein. (Expected MW is 16 kDa)")
![Immunocytochemistry/Immunofluorescence: Survivin Antibody (1H5) [NBP2-22188] - Immunofluorescence analysis of MSCS cells using mouse Survivin Antibody (1H5) [NBP2-22188] (green). Blue: DRAQ5 fluorescent DNA dye. Red: Actin filaments have been labeled with Alexa Fluor-555 phalloidin.](http://images.novusbio.com/fullsize/Survivin-Antibody-1H5-Immunocytochemistry-Immunofluorescence-NBP2-22188-img0002.jpg)
![Immunohistochemistry-Paraffin: Survivin Antibody (1H5) [NBP2-22188] - Immunohistochemical analysis of paraffin-embedded colon cancer tissues using mouse monoclonal Survivin Antibody (1H5) [NBP2-22188] with DAB staining.](http://images.novusbio.com/fullsize/Survivin-Antibody-1H5-Immunohistochemistry-Paraffin-NBP2-22188-img0004.jpg)
![Flow Cytometry: Survivin Antibody (1H5) [NBP2-22188] - Flow cytometric analysis of Jurkat cells using mouse Survivin Antibody (1H5) [NBP2-22188] (green) and negative control (red).](http://images.novusbio.com/fullsize/Survivin-Antibody-1H5-Flow-Cytometry-NBP2-22188-img0001.jpg)
![Western Blot: Survivin Antibody (1H5) [NBP2-22188] - Western blot analysis using [NBP2-22188] against HEK293 (1) and BIRC5 (AA: 1-142)-hIgGFc transfected HEK293 (2) cell lysate. Note: Predicted molecular weight is 16 kDa.](http://images.novusbio.com/fullsize/Survivin-Antibody-1H5-Western-Blot-NBP2-22188-img0006.jpg)
![Immunohistochemistry-Paraffin: Survivin Antibody (1H5) [NBP2-22188] - Immunohistochemical analysis of paraffin-embedded cervical cancer tissues using mouse monoclonal Survivin Antibody (1H5) [NBP2-22188] with DAB staining.](http://images.novusbio.com/fullsize/Survivin-Antibody-1H5-Immunohistochemistry-Paraffin-NBP2-22188-img0003.jpg)
![ELISA: Survivin Antibody (1H5) [NBP2-22188] - ELISA using Survivin Antibody (1H5) [NBP2-22188]. Red: Control Antigen (100ng); Purple: Antigen (10ng); Green: Antigen (50ng); Blue: Antigen (100ng)](http://images.novusbio.com/fullsize/Survivin-Antibody-1H5-ELISA-NBP2-22188-img0005.jpg)